Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Microbiology testing industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Test type trends
2.6 Application trends
2.7 End-use trends
Chapter 3 Microbiology Testing Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Technological Advancements in Microbiology Testing
3.2.1.2 Rising incidence of infectious diseases and outbreak of epidemics
3.2.1.3 Increasing demand for point-of-care testing
3.2.1.4 Rising private-public funding for research on infectious diseases
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of microbiology instruments
3.2.2.2 Dearth of skilled professionals
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By test type
3.3.3 By application
3.3.4 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Reimbursement scenario
3.7 Key market trends
3.8 Technology landscape
3.9 Future market trends
3.10 Value chain analysis
3.11 Gap Analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 Microbiology Testing Market Size and Forecast, By Product (USD Million & Units)
5.1 Key trends, by product
5.2 Instruments
5.3 Reagents
Chapter 6 Microbiology Testing Market Size and Forecast, By Test Type (USD Million)
6.1 Key trends, by test type
6.2 Bacterial
6.3 Viral
6.4 Fungal
Chapter 7 Microbiology Testing Market Size and Forecast, By Application (USD Million)
7.1 Key trends, by application
7.2 Respiratory diseases
7.3 Bloodstream infection
7.4 Gastrointestinal diseases
7.5 Sexually transmitted diseases
7.6 Urinary tract infections
7.7 Periodontal diseases
7.8 Others
Chapter 8 Microbiology Testing Market Size and Forecast, By End-use (USD Million)
8.1 Key trends, by end-use
8.2 Hospitals
8.3 Diagnostic centers
8.4 Academic and research institutes
8.5 Others
Chapter 9 Microbiology Testing Market Size and Forecast, By Region (USD Million & Units)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Sweden
9.3.7 Poland
9.3.8 The Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Thailand
9.4.8 Philippines
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Colombia
9.5.5 Chile
9.5.6 Peru
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Israel
9.6.5 Egypt
9.6.6 Turkey
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Agilent Technologies Inc.
10.3 Beckman Coulter, Inc.
10.4 Becton Dickinson and Company
10.5 Biomerieux SA
10.6 Bio-Rad Laboratories Inc.
10.7 Bruker Corporation
10.8 Danaher Corporation (Cepheid Inc.)
10.9 F. Hoffmann-La Roche Ltd
10.10 Hologic Corporation
10.11 Merck KGaA
10.12 NEOGEN Corporation
10.13 QIAGEN
10.14 Shimadzu Corporation
